What is the treatment for cold sores with Valtrex (valacyclovir)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Cold Sores with Valacyclovir

For cold sores (herpes labialis), valacyclovir 2 grams twice daily for 1 day is the recommended treatment, which should be initiated at the earliest symptoms for maximum effectiveness. 1, 2

Treatment Regimens

First-Line Treatment

  • Valacyclovir 2 grams twice daily for 1 day (single-day therapy) is FDA-approved and most effective when started during the prodromal phase or within 24 hours of symptom onset 1, 2
  • This short-course, high-dose regimen reduces median cold sore episode duration by approximately 1 day compared to placebo 2, 3
  • The 1-day valacyclovir regimen offers greater convenience and potentially better adherence compared to traditional longer courses or topical treatments 2

Alternative Regimens

  • Valacyclovir 500 mg twice daily for 5 days (for those who cannot tolerate the high-dose regimen) 4
  • Famciclovir 125 mg twice daily for 5 days 4
  • Acyclovir 400 mg three times daily for 5 days or 800 mg twice daily for 5 days 4

Timing of Treatment

  • Early initiation is critical - treatment should begin during the prodromal phase (tingling, burning, itching) or within 24 hours of lesion appearance 5, 2
  • Efficacy decreases significantly when treatment is initiated after lesions have fully developed 5, 6
  • Patients should be provided with medication or a prescription in advance so treatment can be initiated promptly at the first sign of symptoms 4

Suppressive Therapy for Frequent Recurrences

  • For patients experiencing 6 or more recurrences per year, suppressive therapy should be considered 4, 6
  • Recommended suppressive regimens include:
    • Valacyclovir 500 mg once daily (can increase to 1000 mg once daily for very frequent recurrences) 4, 6
    • Valacyclovir 250 mg twice daily 4
    • Acyclovir 400 mg twice daily 4
    • Famciclovir 250 mg twice daily 4, 6
  • Daily suppressive therapy reduces recurrence frequency by ≥75% in patients with frequent episodes 4, 6

Special Populations

Immunocompromised Patients

  • Higher doses or longer treatment durations may be required for immunocompromised patients, particularly those with HIV 4, 5
  • For HIV-infected patients, regimens such as acyclovir 400 mg orally three to five times daily until clinical resolution may be beneficial 4
  • Famciclovir 500 mg twice daily has been effective in decreasing recurrence rates and subclinical shedding among HIV-infected patients 4

Dental Procedures

  • For patients with history of herpes labialis triggered by dental procedures, prophylactic valacyclovir (2 grams twice on the day of dental treatment and 1 gram twice the next day) significantly reduces recurrence rates 7

Common Pitfalls to Avoid

  • Relying solely on topical treatments when oral therapy is more effective 5, 6
  • Starting treatment too late (after lesions have fully developed) 5, 2
  • Using inadequate dosing (not using the recommended high-dose, short-course therapy) 6, 2
  • Failing to consider suppressive therapy in patients with frequent recurrences who could significantly benefit 4, 6

Monitoring and Follow-up

  • Assess treatment effectiveness and consider suppressive therapy if recurrences are frequent (≥6 per year) 4, 6
  • After 1 year of continuous suppressive therapy, consider discontinuation to reassess recurrence frequency, as episodes often decrease over time 4
  • Valacyclovir is generally well-tolerated with minimal adverse events (headache, nausea, diarrhea being most common) 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Valacyclovir Treatment for Oral Herpes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Frequent or Severe Cold Sores

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.